Below is Validea's guru fundamental report for MORGAN STANLEY (MS). Of the 22 guru strategies we follow, MS rates highest using our Multi-Factor Investor model based on the published strategy of Pim ...
The role of circulating kidney injury molecule-1 (KIM-1) in metastatic renal cell carcinoma (mRCC): A biomarker analysis of Tide-A, a phase 2 study of first-line avelumab (ave) plus intermittent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback